Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program.
Authors
Hoogenkamp, MaartenLichtinger, Monika
Krysinska, Hanna
Lancrin, Christophe
Clarke, Deborah
Williamson, Andrew J K
Mazzarella, Luca
Ingram, Richard
Jorgensen, Helle
Fisher, Amanda
Tenen, Daniel G
Kouskoff, Valerie
Lacaud, Georges
Bonifer, Constanze
Affiliation
Leeds Institute for Molecular Medicine, University of Leeds, Leeds, United Kingdom.Issue Date
2009-07-09
Metadata
Show full item recordAbstract
At the cellular level, development progresses through successive regulatory states, each characterized by their specific gene expression profile. However, the molecular mechanisms regulating first the priming and then maintenance of gene expression within one developmental pathway are essentially unknown. The hematopoietic system represents a powerful experimental model to address these questions and here we have focused on a regulatory circuit playing a central role in myelopoiesis: the transcription factor PU.1, its target gene colony-stimulating-factor 1 receptor (Csf1r), and key upstream regulators such as RUNX1. We find that during ontogeny, chromatin unfolding precedes the establishment of active histone marks and the formation of stable transcription factor complexes at the Pu.1 locus and we show that chromatin remodeling is mediated by the transient binding of RUNX1 to Pu.1 cis-elements. By contrast, chromatin reorganization of Csf1r requires prior expression of PU.1 together with RUNX1 binding. Once the full hematopoietic program is established, stable transcription factor complexes and active chromatin can be maintained without RUNX1. Our experiments therefore demonstrate how individual transcription factors function in a differentiation stage-specific manner to differentially affect the initiation versus maintenance of a developmental program.Citation
Early chromatin unfolding by RUNX1: a molecular explanation for differential requirements during specification versus maintenance of the hematopoietic gene expression program. 2009, 114 (2):299-309 BloodJournal
BloodDOI
10.1182/blood-2008-11-191890PubMed ID
19339695Type
ArticleLanguage
enISSN
1528-0020ae974a485f413a2113503eed53cd6c53
10.1182/blood-2008-11-191890
Scopus Count
Related articles
- Runx1 promotes murine erythroid progenitor proliferation and inhibits differentiation by preventing Pu.1 downregulation.
- Authors: Willcockson MA, Taylor SJ, Ghosh S, Healton SE, Wheat JC, Wilson TJ, Steidl U, Skoultchi AI
- Issue date: 2019 Sep 3
- The Pu.1 locus is differentially regulated at the level of chromatin structure and noncoding transcription by alternate mechanisms at distinct developmental stages of hematopoiesis.
- Authors: Hoogenkamp M, Krysinska H, Ingram R, Huang G, Barlow R, Clarke D, Ebralidze A, Zhang P, Tagoh H, Cockerill PN, Tenen DG, Bonifer C
- Issue date: 2007 Nov
- Runx1 regulation of Pu.1 corepressor/coactivator exchange identifies specific molecular targets for leukemia differentiation therapy.
- Authors: Gu X, Hu Z, Ebrahem Q, Crabb JS, Mahfouz RZ, Radivoyevitch T, Crabb JW, Saunthararajah Y
- Issue date: 2014 May 23
- DNA methylation of Runx1 regulatory regions correlates with transition from primitive to definitive hematopoietic potential in vitro and in vivo.
- Authors: Webber BR, Iacovino M, Choi SH, Tolar J, Kyba M, Blazar BR
- Issue date: 2013 Oct 24
- Dynamic Runx1 chromatin boundaries affect gene expression in hematopoietic development.
- Authors: Owens DDG, Anselmi G, Oudelaar AM, Downes DJ, Cavallo A, Harman JR, Schwessinger R, Bucakci A, Greder L, de Ornellas S, Jeziorska D, Telenius J, Hughes JR, de Bruijn MFTR
- Issue date: 2022 Feb 9